Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Integral Technologies -- Ignore unavailable to you. Want to Upgrade?

To: VALUESPEC who wrote (321)	4/8/1998 2:44:00 PM
From: Dennis P	Respond to of 1108

Please remember, Integral Tech and IAS are two completely different companies, even though they have certain mutual agreements. I wouldn't expect Mr. Williams to comment on this situation unless and until there are circumstances that directly involve Integral.

To: VALUESPEC who wrote (321)	4/11/1998 11:25:00 AM
From: Pinky	Read Replies (1) \| Respond to of 1108

How can one co-inventor, combine his patent, with the patent of the other co-inventor, and make a new patent, when both principals are mentioned in each previous patent? The Govt. was hard at work on this one, must be the budget surplus. I can't believe a patent attorney was involved on this one. Also, like my friends at Ma Bell, You invent, get your name on the patent, but it still belongs to the co., this case WvU. And, was this not Govt. funded research.

To: VALUESPEC who wrote (321)	4/17/1998 11:35:00 AM
From: Mark S. Williams	Read Replies (1) \| Respond to of 1108

ITKG is not involved in the patent infringement lawsuit which involves IASCA and Dr. Van Voorhies. Therefore, I cannot comment directly on that case. Current Situation: Dr. Van Voorhies is the holder of new patent which covers a very specific design possibility for the CTHA. Ownership of that new patent is in dispute between Van Voorhies and West Virginia University. We have examined our own activities in light of this litigation. CTHA designs currently practiced by ITI/ETC do not infringe on the patent design which is in dispute. Going Forward: From an engineering perspective, we will avoid the disputed design until the dispute is settled, so as not to infringe on Dr. Van Voorhies patent. We do not feel this approach will materially impinge on our capabilities. With this in mind, we are working to quickly conclude contracts with customers on designs which avoid the Van Voorhies patent. We will remain interested in the Van Voorhies dispute, but will not allow it to distract us from our objective, which is to rapidly proliferate the CTHA technology across as many broad and deep markets as possible. Mark Williams, CEO, ITKG williams@itechfin.com